Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

P & G Uses 'Omics for Beauty Product Development

May 25, 2011 10:59 am | News | Comments

Procter & Gamble announced that it will apply its research efforts in the field of 'omics to solve molecular puzzles of beauty and develop new grooming products.


EMA Approves Methylthioninium Chloride Proveblue

May 25, 2011 6:14 am | News | Comments

Provepharm, a biotech start-up specialized in the development of pharmaceutical applications, reports it has received official marketing authorization for its Methylthioninium Chloride Proveblue from the European Medicines Agency.


Technique Explains Cell Division

May 25, 2011 5:26 am | News | Comments

Using a new technique in which models of primitive cells are constructed from the bottom up, scientists have demonstrated that the structure of a cell's membrane and cytoplasm may be as important to cell division as the specialized machinery such as enzymes, DNA, or RNA, found within living cells.


Drug Side Effect Labeling

May 25, 2011 5:02 am | News | Comments

The lists of potential side effects that accompany prescription drugs have ballooned in size, averaging 70 reactions per drug. That number can overwhelm physicians trying to select suitable treatments for their patients, according to a study of drug labels.


Radius Closes $91 Million Financing

May 25, 2011 4:49 am | News | Comments

Radius Health, Inc. has raised approximately $91 million in its third financing round, including $66 million in equity financing and a commitment by GE Capital, Healthcare Financial Services, and Oxford Finance to a $25 million multi-draw term loan facility.


Drug Works Against Acute Lymphoblastic Leukemia

May 25, 2011 4:45 am | News | Comments

An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells greatly reduced the disease for 61% of 46 patients in a phase II study that will be presented at the 47th annual meeting of the American Society of Clinical Oncology.


Researchers Identify How Prostate Cancer Cells Bulk Up

May 25, 2011 4:40 am | News | Comments

Stopping prostate cancer cells from bulking up with nutrients reduces the spread of the disease and tumor size.


Particle Trap Paves Way for Personalized Medicine

May 24, 2011 12:58 pm | News | Comments

Sequencing DNA base pairs is key for medical researchers working toward personalized medicine. Being able to isolate, study, and sequence these molecules would allow scientists to tailor diagnostic testing, therapies, and treatments to patients.


Thermo Fisher Acquires Sterilin

May 24, 2011 12:53 pm | News | Comments

Thermo Fisher Scientific Inc. announced that it has acquired Sterilin Ltd., a leading provider of consumable products for microbiology, life science and clinical laboratories.


Disposable Trays

May 24, 2011 12:48 pm | Product Releases | Comments

Porvair Sciences offers a wide range of disposable Reservoir trays designed for use with any robotic liquid handling system. Reservoirs are available offering options to accommodate a single liquid or partitioned space for several liquids.


Dynamic Light Scattering System

May 24, 2011 12:45 pm | Drug Discovery & Development | Product Releases | Comments

The W130i from Avid Nano is a breakthrough, high sensitivity dynamic light scattering system for size and molecular weight measurement of proteins, biomolecules and nanoparticles.


Mylan Selling Generic Depakote

May 24, 2011 12:37 pm | News | Comments

Mylan Inc. said it started selling a generic version of Abbott Laboratories' anti-seizure treatment Depakote Sprinkles capsules. The drugmaker said it is selling 125-milligram capsules of divalproex sodium.


Rifadin Granted New Approval

May 24, 2011 12:33 pm | News | Comments

Daiichi Sankyo Company, Limited announced that it received approval in Japan for a supplemental New Drug Application for an additional indication of Rifadin 150 mg capsules for nontuberculous mycobacterial disease.


Bacteria May Have Role in Asthma

May 24, 2011 12:23 pm | News | Comments

People with severe asthma are more likely to have antibodies against the disease-causing bacteria Chlamydia pneumoniae than the general population and in some cases antibiotic treatment can greatly improve symptoms.


Protein May Lead to Heart Failure

May 24, 2011 12:21 pm | News | Comments

Researchers discovered a protein switch which can trigger a cascade of events leading to heart failure, pointing to a new direction for drug development.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.